在生物医药行业不断发展的背景下，德展健康（股票代码：000813）于2024年3月11日举行了重要的投资者关系活动，展现了公司在创新药研发及未来发展战略上的雄心壮志。今年，德展健康在营业收入上取得不错成绩：2023年，他们的营业收入达到了4.98亿元，而在2024年前三季度，收入为3.54亿元，其中主打产品“阿乐”和“尼乐”占据了整体现收入的九成以上。

FAIRFAX, VA / ACCESS Newswire / February 18, 2025 / WidePoint Corporation (NYSE American:WYY) , an innovative leader in enterprise cybersecurity and mobile technology, today announced its fiscal ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

FAIRFAX, VA / / February 24, 2025 / WidePoint Corporation (NYSE American:WYY), an innovative leader in enterprise cybersecurity and mobile technology, announced today that its Intelligent Technology ...